Archiv der Pharmazie · 2011 · 12 citations · 12 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsChemical Library DesignHeterocyclic ChemistryLigand-based DesignPotency OptimizationStructure-activity Relationship AnalysisCyclooxygenase InhibitorsCyclooxygenase-2 PathwayInhibitor ClassificationMedicinal Chemistry ApplicationsMedicinal HeterocyclesPharmacological ScreeningSelective Cyclooxygenase-2 InhibitorsSelectivity
A new group of regioisomeric 2,3-diaryl-1,3-benzdiazinan-4-ones, possessing a methyl sulfonyl pharmacophore, were synthesized and their biological activities were tested for cyclooxygenase-2 (COX-2) inhibitory activity. In vitro COX-1/COX-2 inhibition studies identified 3-(p-fluorophenyl)-2-(4-methylsulfonylphenyl)-1,3-benzdiazinane-4-one (2b) as a potent and highly selective (IC(50) = 0.07 µM; selectivity index = 572.8) COX-2 inhibitor.
12
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Ravi G. Kurumbail, Anna M. Stevens, James K. Gierse et al. · Nature · 1996 · 1.9K citations